Jacob Bayer

Current Contract

Contract Value Index (CVI)

Jacob Bayer's value math nets a C+ Contract Value Index — placing the deal in a clear band relative to the league median at center. At $885K AAV on a practice squad signing, Bayer carries minimal financial risk for Cincinnati, but the contract reflects organizational skepticism about his immediate upside rather than a vote of confidence. His D+ performance grade from the 2025 season aligns with the media narrative of him as depth competition rather than a roster cornerstone, and at 23 years old in his rookie season, he remains several steps removed from commanding meaningful snaps or dollars. The Bengals' recent acquisitions — edge rushers, defensive backs, running backs, and interior linemen across multiple moves — underscore that front-office investment priorities lie elsewhere, leaving Bayer firmly in the "low-cost camp competition" tier. Unless injuries force his hand, he's unlikely to see meaningful regular-season action, making this deal exactly what it appears: a speculative depth flyer with downside protection and no upside ceiling. The C+ CVI reflects a contract that neither punishes Cincinnati nor positions Bayer to prove franchise-caliber value; it's organizational indifference priced into cap-friendly terms, suitable for a player the beat coverage describes as the "forgotten center" on the roster depth chart.

Contracts in the Same Value Band

Other same-position deals the Contract Value Index also places in the C band — a quick read on where Jacob's contract sits relative to comparable money.

Performance Analysis

Jacob Bayer sits firmly in replacement-level territory among NFL centers, a practice squad addition who represents the bottom tier of his position at this stage of his career. At just 23 years old in his rookie season, there is theoretical developmental upside, but the data tells a story of a player who has appeared in only 3 games and carries no meaningful production signal to evaluate — making a strong performance case nearly impossible to construct. The age factor works in his favor as about the only bright spot in this evaluation, reflecting the raw youth that keeps his long-term ceiling technically open, though that ceiling looks low given the current trajectory. His salary situation reflects the floor of NFL contract value, earning a D+ Contract Value Index (CVI) that is steady but uninspiring — the kind of number you see attached to camp bodies cycling through roster spots rather than contributors. The media framing tells you everything you need to know: five headlines, mostly roster-update filler, with the most notable contextual hook being his Arkansas State background and its connection to regional interest — not his play. Cincinnati fans are largely indifferent, viewing Bayer as a camp body behind an established offensive line, and the release of C Matt Lee earlier this offseason only underscores that the Bengals are actively managing depth at the position rather than investing in it. With the regular season still 134 days away, Bayer's path to a 53-man roster spot looks narrow, and a brief practice squad stint with long odds of seeing regular-season action is the most realistic outcome here.

How Jacob Compares at the Position

Jacob Bayer ranks 32nd of 71 graded centers by performance. That slots Jacob between Trystan Colon (C) just ahead and Sedrick Van Pran-granger (D) just behind.

Fan Sentiment

Fan reaction and beat coverage cluster around a D- sentiment grade for Jacob Bayer. The narrative framing is less about criticism and more about complete organizational indifference — he's a practice squad depth signing in a rookie season, and media outlets covering his addition treat it as routine roster bookkeeping rather than a meaningful acquisition. His 2025 season production, which graded at D+, aligns perfectly with the sentiment silence; he appeared in minimal action without establishing himself as anything beyond replacement-level depth at center. The Bengals' recent roster moves tell the story Cincinnati's front office is actually telling — they've signed edge rushers, defensive backs, and a running back in recent weeks, while separately trading a first-round pick for Dexter Lawrence II, signaling their investment priorities lie nowhere near Bayer's position. Unless injuries force meaningful snaps in his direction, Bayer remains firmly in the "forgotten unless desperate" category, and there's no narrative momentum or beat coverage suggesting that perception will shift heading into the 2026 season.